CN107875170B - 一种含有碳酸钙的泡腾剂 - Google Patents
一种含有碳酸钙的泡腾剂 Download PDFInfo
- Publication number
- CN107875170B CN107875170B CN201711106917.XA CN201711106917A CN107875170B CN 107875170 B CN107875170 B CN 107875170B CN 201711106917 A CN201711106917 A CN 201711106917A CN 107875170 B CN107875170 B CN 107875170B
- Authority
- CN
- China
- Prior art keywords
- calcium carbonate
- effervescent
- mixture
- mixing
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title claims abstract description 316
- 229910000019 calcium carbonate Inorganic materials 0.000 title claims abstract description 158
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 46
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 134
- 239000000203 mixture Substances 0.000 claims abstract description 74
- 238000002156 mixing Methods 0.000 claims abstract description 55
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 43
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000001630 malic acid Substances 0.000 claims abstract description 43
- 235000011090 malic acid Nutrition 0.000 claims abstract description 43
- 238000001556 precipitation Methods 0.000 claims abstract description 20
- 239000008187 granular material Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000009472 formulation Methods 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000013355 food flavoring agent Nutrition 0.000 claims description 8
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 7
- 229930003316 Vitamin D Natural products 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 7
- 239000003086 colorant Substances 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 7
- 229960002442 glucosamine Drugs 0.000 claims description 7
- 239000011710 vitamin D Substances 0.000 claims description 7
- 235000019166 vitamin D Nutrition 0.000 claims description 7
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 7
- 229940046008 vitamin d Drugs 0.000 claims description 7
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 229920002567 Chondroitin Polymers 0.000 claims description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 238000004040 coloring Methods 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000002244 precipitate Substances 0.000 abstract description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 15
- 239000011575 calcium Substances 0.000 abstract description 15
- 229910052791 calcium Inorganic materials 0.000 abstract description 15
- 239000000047 product Substances 0.000 abstract description 11
- 238000010521 absorption reaction Methods 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000035622 drinking Effects 0.000 abstract description 3
- 229960004106 citric acid Drugs 0.000 description 38
- 235000015165 citric acid Nutrition 0.000 description 38
- 239000002253 acid Substances 0.000 description 24
- 238000000034 method Methods 0.000 description 23
- 230000008569 process Effects 0.000 description 13
- 239000007938 effervescent tablet Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000004376 Sucralose Substances 0.000 description 5
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 5
- 235000019408 sucralose Nutrition 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 230000009747 swallowing Effects 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000005913 Maltodextrin Substances 0.000 description 3
- 229920002774 Maltodextrin Polymers 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 229940069978 calcium supplement Drugs 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000004222 ferrous gluconate Substances 0.000 description 3
- 235000013924 ferrous gluconate Nutrition 0.000 description 3
- 229960001645 ferrous gluconate Drugs 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 3
- 229940035034 maltodextrin Drugs 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000011647 vitamin D3 Substances 0.000 description 3
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 235000003351 Brassica cretica Nutrition 0.000 description 2
- 235000003343 Brassica rupestris Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 2
- 229940085865 calcium carbonate 750 mg Drugs 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- -1 compound calcium carbonate Chemical class 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000010460 mustard Nutrition 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000007911 effervescent powder Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 229940024898 povidone k30 Drugs 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
- A23L2/395—Dry compositions in a particular shape or form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Description
方1 | 方2 | 方3 | 方4 | 方5 | 方6 | 方7 | 方8 | |
碳酸钙 | 750mg | 750mg | 750mg | 750mg | 750mg | 750mg | 750mg | 750mg |
柠檬酸 | 750mg | 0 | 1500mg | 0 | 750mg | 1500mg | 500mg | 500mg |
苹果酸 | 0 | 750mg | 0 | 1500mg | 750mg | 375mg | 500mg | 375mg |
乳糖 | 500mg | 500mg | 500mg | 500mg | 500mg | 500mg | 500mg | 500mg |
单剂量,合计 | 2g | 2g | 2.75g | 2.75g | 2.75g | 3.125g | 2.25g | 2.125g |
方1 | 方2 | 方3 | 方4 | 方5 | 方6 | 方7 | 方8 | |
静置5分钟 | ++ | ++ | ++ | ++ | —— | + | —— | + |
静置0.5小时 | +++ | +++ | +++ | +++ | + | ++ | + | ++ |
静置1小时 | +++ | ++++ | +++ | ++++ | + | ++ | + | ++ |
静置4小时 | +++ | ++++ | +++ | ++++ | + | ++ | + | ++ |
沉淀重量 | 104mg | 136mg | 87mg | 125mg | 29mg | 55mg | 30mg | 62mg |
方9 | 方10 | 方11 | 方12 | 方13 | 方14 | 方15 | 方16 | |
静置5分钟 | —— | —— | —— | —— | —— | —— | —— | —— |
静置0.5小时 | + | + | + | ± | —— | —— | —— | —— |
静置1小时 | + | + | + | ± | —— | —— | —— | ± |
静置4小时 | + | + | + | ± | —— | —— | —— | ± |
沉淀重量 | 26mg | 23mg | 17mg | 12mg | 0mg | 0mg | 0mg | 8mg |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711106917.XA CN107875170B (zh) | 2017-11-10 | 2017-11-10 | 一种含有碳酸钙的泡腾剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711106917.XA CN107875170B (zh) | 2017-11-10 | 2017-11-10 | 一种含有碳酸钙的泡腾剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107875170A CN107875170A (zh) | 2018-04-06 |
CN107875170B true CN107875170B (zh) | 2020-07-07 |
Family
ID=61780148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711106917.XA Active CN107875170B (zh) | 2017-11-10 | 2017-11-10 | 一种含有碳酸钙的泡腾剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107875170B (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000107A1 (en) * | 1992-06-30 | 1994-01-06 | The Procter & Gamble Company | Effervescent calcium supplements |
CN101721387A (zh) * | 2009-12-24 | 2010-06-09 | 山东达因海洋生物制药股份有限公司 | 一种碳酸钙泡腾剂及其制备方法 |
WO2011053265A2 (en) * | 2009-11-02 | 2011-05-05 | Bilgic Mahmut | The parmaceutical compositions comprising calcium and vitamin d |
CN102225070A (zh) * | 2011-05-27 | 2011-10-26 | 黄辉 | 一种碳酸钙泡腾颗粒剂 |
CN104173370A (zh) * | 2013-05-22 | 2014-12-03 | 上海诺成药业股份有限公司 | 一种含钙泡腾片及其制备方法和用途 |
CN104257624A (zh) * | 2014-09-10 | 2015-01-07 | 天津爱勒易医药材料有限公司 | 一种新的泡腾崩解预混剂及其制备方法 |
CN105496983A (zh) * | 2016-01-21 | 2016-04-20 | 国药集团汕头金石制药有限公司 | 牡蛎碳酸钙泡腾片组合物及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130164342A1 (en) * | 2010-06-03 | 2013-06-27 | Mahmut Bilgic | Formulations for osteoporosis |
-
2017
- 2017-11-10 CN CN201711106917.XA patent/CN107875170B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000107A1 (en) * | 1992-06-30 | 1994-01-06 | The Procter & Gamble Company | Effervescent calcium supplements |
WO2011053265A2 (en) * | 2009-11-02 | 2011-05-05 | Bilgic Mahmut | The parmaceutical compositions comprising calcium and vitamin d |
CN101721387A (zh) * | 2009-12-24 | 2010-06-09 | 山东达因海洋生物制药股份有限公司 | 一种碳酸钙泡腾剂及其制备方法 |
CN102225070A (zh) * | 2011-05-27 | 2011-10-26 | 黄辉 | 一种碳酸钙泡腾颗粒剂 |
CN104173370A (zh) * | 2013-05-22 | 2014-12-03 | 上海诺成药业股份有限公司 | 一种含钙泡腾片及其制备方法和用途 |
CN104257624A (zh) * | 2014-09-10 | 2015-01-07 | 天津爱勒易医药材料有限公司 | 一种新的泡腾崩解预混剂及其制备方法 |
CN105496983A (zh) * | 2016-01-21 | 2016-04-20 | 国药集团汕头金石制药有限公司 | 牡蛎碳酸钙泡腾片组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
泡腾钙片的研制;冷桂华;《食品工业》;20081231(第3期);第47-49页 * |
维C佳钙泡腾片的处方工艺研究;黄晓燕等;《药物研究》;20080531;第5卷(第15期);第38-40页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107875170A (zh) | 2018-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019362348A1 (en) | Micro-effervescent buccal tablet and preparation method thereof | |
US20070298100A1 (en) | Compressed Pharmaceutical Compositions Comprising Peg and Electrolytes | |
JPH0789852A (ja) | 高濃度のカルシウムを含有する水溶性粉末およびその 製造方法 | |
JPH06507640A (ja) | 混合カルシウム及びビタミンd補給品 | |
JPH10505850A (ja) | 単体ガレヌス錠剤の形態の治療用ビタミン−カルシウム複合剤、その製造法および使用法 | |
US20240122969A1 (en) | Enhanced nitrate compositions and methods of use | |
CN102085356B (zh) | 一种用于增加骨密度的组合物及其制备方法 | |
CN101103960B (zh) | 一种含有消旋卡多曲的干混悬剂及其制备方法 | |
CN104434865A (zh) | 一种维生素c泡腾片的组分及制备 | |
CN104068306B (zh) | 一种增加骨密度的保健食品及其制备方法 | |
NO168563B (no) | Anvendelse av en organoleptisk akseptabel blanding av magnesiumsalter som mineraladditiv | |
GB2366713A (en) | Food product containing natto powder | |
CN107875170B (zh) | 一种含有碳酸钙的泡腾剂 | |
JP2003532396A (ja) | 微粉化された真珠母粉末を含む食用組成物 | |
US20040009235A1 (en) | Nanometer grade hydroxyapatite composition for replenishing calcium | |
CN107308216B (zh) | 一种复方甘草口含片及其制备方法 | |
CN102657643B (zh) | 一种复合有机酸钙泡腾片及其制备方法 | |
TWI530256B (zh) | 以鐵結合型乳鐵蛋白製備抗精神疲勞劑之方法 | |
CN1907269A (zh) | 氨基葡萄糖复合泡腾制剂 | |
CN1303904C (zh) | 橄榄钙片 | |
JP4655338B2 (ja) | 鉄欠乏性貧血改善のための薬剤 | |
KR100729847B1 (ko) | 쓴 맛이 차폐된 글루콘산아연 경구투여용 제제 조성물 | |
JP2007039408A (ja) | 微粉化クレアチンとその製造方法 | |
US20150024064A1 (en) | pKa Buffered Vitamin C Composition and Method | |
CN117224500A (zh) | 一种高钙含量的葡萄糖酸钙锌泡腾片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20180406 Assignee: Jiangsu Jinmao Finance Leasing Co.,Ltd. Assignor: JIANGSU YANGXIN BIOMEDICAL CO.,LTD. Contract record no.: X2023320010012 Denomination of invention: An effervescent agent containing calcium carbonate Granted publication date: 20200707 License type: Exclusive License Record date: 20230110 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: An effervescent agent containing calcium carbonate Effective date of registration: 20230111 Granted publication date: 20200707 Pledgee: Jiangsu Jinmao Finance Leasing Co.,Ltd. Pledgor: JIANGSU YANGXIN BIOMEDICAL CO.,LTD. Registration number: Y2023320010031 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Jiangsu Jinmao Finance Leasing Co.,Ltd. Assignor: JIANGSU YANGXIN BIOMEDICAL CO.,LTD. Contract record no.: X2023320010012 Date of cancellation: 20240203 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20200707 Pledgee: Jiangsu Jinmao Finance Leasing Co.,Ltd. Pledgor: JIANGSU YANGXIN BIOMEDICAL CO.,LTD. Registration number: Y2023320010031 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |